Assenagon Asset Management S.A., a registered investment adviser, initiated a new position in Boston Scientific Corporation (NYSE:BSX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 4,306,176 shares of the Healthcare company, valued at approximately $410,593,882 as of the filing date.
Boston Scientific Corporation's stock currently trades at $97.64 with a market capitalization of $135,976,996,027.
